Lyell Immunopharma
LYEL
LYEL
93 hedge funds and large institutions have $823M invested in Lyell Immunopharma in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
20% more capital invested
Capital invested by funds: $689M → $823M (+$135M)
0.12% more ownership
Funds ownership: 2.15% → 2.27% (+0.12%)
Holders
93
Holding in Top 10
5
Calls
$15K
Puts
–
Top Buyers
| 1 | +$20.4M | |
| 2 | +$13M | |
| 3 | +$12.7M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$7.88M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$6.12M |
Top Sellers
| 1 | -$24.1M | |
| 2 | -$10.7M | |
| 3 | -$1.18M | |
| 4 |
SG Americas Securities
New York
|
-$298K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$153K |